The study “GP awareness about chemoprevention” was carried out on behalf of Cancer Research UK, and aimed to specifically explore GP awareness on tamoxifen and aspirin use with breast and bowel cancers.
The survey took place in May 2016 in the UK and involved over 1,000 physicians from our panel. You can access the study here and see a summary together with the main findings below.
Breakthrough in detecting testicular cancer: a blood-based diagnostic method identifies germ cell tumours missed by standard tests
Ageing lungs undergo a series of structural and cellular changes that increase vulnerability to respiratory infections such as influenza and COVID-19, according to a review
Bowel cancer immunotherapy trial shows no relapses, with NEOPRISM-CRC results at the American Association for Cancer Research.